The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Columnist Kristin Neva and her husband with ALS are sometimes asked about the way they went about building their accessible home.

Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...

Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions.

Drinking straws are one of the tools in columnist Dagmar Munn's arsenal to combat dysphagia while living with ALS.

Altered activity of ancient viral genes were linked to neurodegenerative diseases including ALS in a recent analysis.

Biotech company Auttx has received a $125,000 grant to advance the development of new molecules that aim to restore normal RNA processing in people with amyotrophic lateral sclerosis (ALS), ...